The overall objective of this Core is to provide centralized, efficient mechanisms by which the scientific program can be monitored, evaluated and continuously improved to assure viability for the next generation of investigators in sex-differences research. This objective will be achieved through four aims: 1. Provide scientific leadership for the entire program, 2.Provide efficient and centralized administration for the SCOR investigators, 3. Provide enhanced mentorship of BIRCWCH scholars through SCOR programs and 4. Provide enhanced dissemination of research findings to the broader scientific and clinical practice communities. Scientific leadership will be the responsibility of the Program Director and Co-director in collaboration with the Internal Executive Advisory Committee. Centralization of office operations will be cost effective for quality assurance, compliance, communication, record keeping and organization necessary for integrating programs with those of the BIRCWH and CTSA and for the dissemination of research findings. Joint seminars, workshops and research forums will be organized in conjunction with ongoing programs sponsored by the Women's Health Clinic, Office of Women's Health, CTSA and BIRCWH programs. The Program Director with the Administrative Coordinator will establish timelines for abstract and manuscript deadlines and prioritize other projects requiring major time commitments. Through the Program Director's activities with the Organization for the Study of Sex Differences, the Society for Women's Health Research, the International Society for Gender Medicine as well as through the involvement of other members of the SCOR investigative team with their professional societies representing eleven different disciplines, dissemination of the research findings will have global impact.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG044170-03
Application #
8733126
Study Section
Special Emphasis Panel (ZRG1-EMNR-Q)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
$95,810
Indirect Cost
$35,552
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Beckman, J P; Camp, J J; Lahr, B D et al. (2018) Pregnancy history, coronary artery calcification and bone mineral density in menopausal women. Climacteric 21:53-59
Kattah, Andrea G; Suarez, Maria L G; Milic, Natasa et al. (2018) Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis. Menopause 25:625-634
Ramanan, Vijay K; Przybelski, Scott A; Graff-Radford, Jonathan et al. (2018) Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults. J Alzheimers Dis 65:1345-1352
Rocca, Walter A; Gazzuola Rocca, Liliana; Smith, Carin Y et al. (2018) Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study. Maturitas 117:64-77
Mielke, Michelle M; Hagen, Clinton E; Xu, Jing et al. (2018) Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 14:989-997
Barnes, Jill N; Harvey, Ronée E; Miller, Kathleen B et al. (2018) Cerebrovascular Reactivity and Vascular Activation in Postmenopausal Women With Histories of Preeclampsia. Hypertension 71:110-117
Gao, Catherine C; Kapoor, Ekta; Lipford, Melissa C et al. (2018) Association of vasomotor symptoms and sleep apnea risk in midlife women. Menopause 25:391-398
Laughlin-Tommaso, Shannon K; Khan, Zaraq; Weaver, Amy L et al. (2018) Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 25:483-492
Wennberg, Alexandra M V; Hagen, Clinton E; Edwards, Kelly et al. (2018) Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging. Int J Geriatr Psychiatry 33:1114-1120
Knopman, David S; Lundt, Emily S; Therneau, Terry M et al. (2018) Joint associations of ?-amyloidosis and cortical thickness with cognition. Neurobiol Aging 65:121-131

Showing the most recent 10 out of 160 publications